Literature DB >> 31022479

Aqueous extract of Salvia miltiorrhiza Bunge-Radix Puerariae herb pair ameliorates diabetic vascular injury by inhibiting oxidative stress in streptozotocin-induced diabetic rats.

Wenwen Zhao1, Yuan Yuan2, Haiyu Zhao3, Yantao Han4, Xiuping Chen5.   

Abstract

Vascular diabetic complications are the leading cause of mortality and morbidity for diabetes. The present study was designed to investigate the protective effect of herb pair Salvia miltiorrhiza Bunge-Radix Puerariae (DG) on diabetic vascular injury induced by streptozotocin. The protective effect of DG was determined by oral administration of DG (50 and 200 mg/kg) in rats and on high glucose (HG)-induced endothelial injury. DG showed no effect on body weight, fasting blood glucose (FBG) but decreased the serum levels of insulin, nitric oxide (NO), hydrogen peroxide (H2O2), malondialdehyde (MDA), soluble intercellular cell adhesion molecule-1 (s-ICAM-1) and vascular cell adhesion molecule-1 (s-VCAM-1), and increased superoxide dismutase (SOD) and catalase (CAT) levels. The pathological alterations of aorta was improved by DG. Furthermore, the increased expression of ICAM-1,VCAM-1, NOX2, and NOX4 in aorta were inhibited by DG. HG-induced endothelial ROS formation, ICAM-1,VCAM-1, NOX4 expression and monocyte-endothelial adhesion were dramatically suppressed by DG as well. In addition, both GKT137831, a NOX4 inhibitor, and PDTC, a NF-κB inhibitor, could significantly inhibited HG-induced ICAM-1, VCAM-1 expression and monocyte-endothelial adhesion. These results suggested that DG improved diabetic vascular injury possibly by reducing oxidative stress, which provides scientific evidence for the application of DG for diabetic vascular therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell adhesion molecules; Diabetic vascular injury; Oxidative stress; Radix puerariae; Salvia miltiorrhiza bunge

Mesh:

Substances:

Year:  2019        PMID: 31022479     DOI: 10.1016/j.fct.2019.04.018

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Investigating the Molecular Mechanism of Quercetin Protecting against Podocyte Injury to Attenuate Diabetic Nephropathy through Network Pharmacology, MicroarrayData Analysis, and Molecular Docking.

Authors:  Xiaoqin Ma; Chenxia Hao; Meixiang Yu; Zhaokang Zhang; Jingjing Huang; Wanhua Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-16       Impact factor: 2.650

2.  Multiple-Tissue and Multilevel Analysis on Differentially Expressed Genes and Differentially Correlated Gene Pairs for HFpEF.

Authors:  Guofeng Zhou; Shaoyan Sun; Qiuyue Yuan; Run Zhang; Ping Jiang; Guangyu Li; Yong Wang; Xiao Li
Journal:  Front Genet       Date:  2021-07-08       Impact factor: 4.599

3.  Traditional Chinese Medicine Shen-Yuan-Dan (SYD) Improves Hypoxia-Induced Cardiomyocyte Apoptosis in Neonatal Rats by Upregulating miR-24/Bim Pathway.

Authors:  Fuyong Chu; Xue Yan; Xingjiang Xiong; Mingxue Zhou; Yupei Tan; Yixuan Li; Wei Liu; Hongxu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-03       Impact factor: 2.629

4.  Cryptotanshinone Suppressed Postmenopausal Osteoporosis by Preventing RANKL-Mediated Osteoclastogenesis against Kidney Injury.

Authors:  Wenjiu Yang; Jing Han; Shuo Gong; Jun Zhao; Tengbo Yu; Jinfeng Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-29       Impact factor: 2.629

5.  Rapid quantification of bioactive compounds in Salvia miltiorrhiza Bunge derived decoction pieces, dripping pill, injection, and tablets by polarity-switching UPLC-MS/MS.

Authors:  Qing Shen; Haixing Wang; Bin Quan; Xiuhua Sun; Guohua Wu; Darong Huang; Qingcheng Wang; Pei Luo
Journal:  Front Chem       Date:  2022-07-15       Impact factor: 5.545

6.  An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Authors:  Min-Han Chi; Jung Chao; Chien-Yu Ko; Shyh-Shyun Huang
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.